Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primaquine PK in Lactating Women and Breastfed Infants
NCT06191458Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Jul 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of primaquine in malaria and Plasmodium ovale malaria, sponsored by University of Oxford. Primary endpoints: Area under the time-concentration curve in milk at 14 days and Relative infant dose at 14 days. Started Jul 2024; status: completed.
02
Drugs
primaquine
03
Conditions
malariaPlasmodium ovale malaria
Beyond the preview
Go deeper on NCT06191458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06191458.